CRISPR Therapeutics AG Profile Avatar - Palmy Investing

CRISPR Therapeutics AG

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRIS…

Biotechnology
CH, Zug [HQ]
CH · Macroeconomic Factors/Risks · Forecasts

Macro

CRISPR Therapeutics AG mainly operates in CH (Alpha-2: CH, Alpha-3: CHE)

Switzerland
Analysis Results
B Overall Rating
18 Analyzed Indicators
C+ Annual Indicators Rating
16 Analyzed Indicators
A Monthly Indicators Rating
2 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of CRSP's Analysis
CIK: 1674416 CUSIP: H17182108 ISIN: CH0334081137 LEI: - UEI: -
Secondary Listings
CRSP has no secondary listings inside our databases.